Optimization of systemic AAV9 gene therapy in Niemann-Pick disease, type C1 mice
{{output}}
Niemann-Pick disease, type C1 (NPC1), is a rare, fatal neurodegenerative disorder caused by pathological variants in NPC1, which encodes a lysosomal cholesterol transporter. FDA-approved treatments are limited and do not target the underlying genetic defect. B... ...
